AP-1126

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAP-1126
Drug Alias NameJZP-7AP-1126
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsRestless Legs Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAntares Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAntares PharmaJazz Pharmaceuticals Plc
Active IndicationsN/A
Inactive IndicationsRestless Legs Syndrome

Other Information

ATC CodeN/A
Related LinksN/A